1
|
Figueiró Longo JP, Camargo NS, Andrade SS, Vasconcelos AG, SA Leite JR. Nanotechnological innovations in dermo-cosmetics: lessons for nanomedicine advancement. Nanomedicine (Lond) 2024; 19:1425-1429. [PMID: 39011844 PMCID: PMC11318698 DOI: 10.1080/17435889.2024.2367959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Accepted: 06/11/2024] [Indexed: 07/17/2024] Open
Affiliation(s)
- João Paulo Figueiró Longo
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil
- Department of Science & Innovation, Glia Innovation, Goiânia, Goiás, Brazil
| | - Nichollas Serafim Camargo
- Department of Science & Innovation, Glia Innovation, Goiânia, Goiás, Brazil
- Plateinnove Biotechnology, Sorocaba, São Paulo, Brazil
| | - Sheila Siqueira Andrade
- Department of Science & Innovation, Glia Innovation, Goiânia, Goiás, Brazil
- Plateinnove Biotechnology, Sorocaba, São Paulo, Brazil
| | - Andreanne Gomes Vasconcelos
- Research Center in Applied Morphology and Immunology, NuPMIA, Faculty of Medicine, University of Brasilia, UnB, Brasília, DF, Brazil
- People & Science Research, Development and Innovation LTDA, BrasíliaDF, Brazil
| | - José Roberto SA Leite
- Research Center in Applied Morphology and Immunology, NuPMIA, Faculty of Medicine, University of Brasilia, UnB, Brasília, DF, Brazil
- People & Science Research, Development and Innovation LTDA, BrasíliaDF, Brazil
| |
Collapse
|
2
|
Siqueira Andrade S, Faria AVDS, Augusto Sousa A, da Silva Ferreira R, Camargo NS, Corrêa Rodrigues M, Longo JPF. Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective. Adv Drug Deliv Rev 2024; 205:115156. [PMID: 38104897 DOI: 10.1016/j.addr.2023.115156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Revised: 12/01/2023] [Accepted: 12/09/2023] [Indexed: 12/19/2023]
Abstract
In recent decades, a sweeping technological wave has reshaped the global economic landscape. Fueled by the unceasing forces of digital innovation and venture capital investment, this transformative machine has left a significant mark across numerous economic sectors. More recently, the emergence of 'deep tech' start-ups, focusing on areas such as artificial intelligence, nanotechnology, and biotechnology, has infused a fresh wave of innovation into various sectors, including the pharmaceutical and cosmetic industry. This review explores the significance of innovation within the cosmetics sector, with a particular emphasis on delivery systems. It assesses the crucial process of bridging the gap between research and the market, particularly in the translation of nanotechnology into tangible real-world applications. With the rise of nanotechnology-based beauty ingredients, we can anticipate groundbreaking advancements that promise to surpass consumer expectations, ushering in a new era of unparalleled innovation in beauty products.
Collapse
Affiliation(s)
- Sheila Siqueira Andrade
- PlateInnove Biotechnology, Sorocaba, São Paulo, Brazil; Department of Science and Innovation, Glia Innovation, Goiânia, Goiás, Brazil
| | - Alessandra Valéria de Sousa Faria
- Department of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil
| | | | | | | | - Mosar Corrêa Rodrigues
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasilia, Brazil
| | - João Paulo Figueiró Longo
- Department of Science and Innovation, Glia Innovation, Goiânia, Goiás, Brazil; Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasilia, Brazil.
| |
Collapse
|
3
|
de Oliveira JV, Oliveira da Rocha MC, de Sousa-Junior AA, Rodrigues MC, Farias GR, da Silva PB, Bao SN, Bakuzis AF, Azevedo RB, Morais PC, Muehlmann LA, Figueiró Longo JP. Tumor vascular heterogeneity and the impact of subtumoral nanoemulsion biodistribution. Nanomedicine (Lond) 2022; 17:2073-2088. [PMID: 36853205 DOI: 10.2217/nnm-2022-0176] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023] Open
Abstract
Aim: Investigate the heterogeneous tumor tissue organization and examine how this condition can interfere with the passive delivery of a lipid nanoemulsion in two breast cancer preclinical models (4T1 and Ehrlich). Materials & methods: The authors used in vivo image techniques to follow the nanoemulsion biodistribution and microtomography, as well as traditional histopathology and electron microscopy to evaluate the tumor structural characteristics. Results & conclusion: Lipid nanoemulsion was delivered to the tumor, vascular organization depends upon the subtumoral localization and this heterogeneous organization promotes a nanoemulsion biodistribution to the highly vascular peripherical region. Also, the results are presented with a comprehensive mathematical model, describing the differential biodistribution in two different breast cancer models, the 4T1 and Ehrlich models.
Collapse
Affiliation(s)
| | | | | | - Mosar Corrêa Rodrigues
- Institute of Biological Sciences, University of Brasília, Brasília, DF, 70910-900, Brazil
| | - Gabriel Ribeiro Farias
- Institute of Biological Sciences, University of Brasília, Brasília, DF, 70910-900, Brazil
| | | | - Sônia Nair Bao
- Institute of Biological Sciences, University of Brasília, Brasília, DF, 70910-900, Brazil
| | | | - Ricardo Bentes Azevedo
- Institute of Biological Sciences, University of Brasília, Brasília, DF, 70910-900, Brazil
| | - Paulo César Morais
- Institute of Physics, University of Brasília, Brasília, DF, 70910-900, Brazil
- Biotechnology & Genomic Sciences, Catholic University of Brasília, Brasília, DF, 70790-160, Brazil
| | | | | |
Collapse
|
4
|
Galdino de Souza D, Santos DS, Simon KS, Morais JAV, Coelho LC, Pacheco TJA, Azevedo RB, Bocca AL, Melo-Silva CA, Longo JPF. Fish Oil Nanoemulsion Supplementation Attenuates Bleomycin-Induced Pulmonary Fibrosis BALB/c Mice. NANOMATERIALS 2022; 12:nano12101683. [PMID: 35630905 PMCID: PMC9145453 DOI: 10.3390/nano12101683] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Revised: 04/27/2022] [Accepted: 05/05/2022] [Indexed: 02/06/2023]
Abstract
Diets rich in omega-3 or -6 fatty acids will produce different profiles for cell membranes phospholipid constitutions. Omegas 3 and 6 are part of the diet and can modulate the inflammatory profile. We evaluated the effects of the oral absorption of fish oil, when associated with a lipid nanoemulsion in an experimental pulmonary inflammatory model. Pulmonary fibrosis is a disease associated with excessive extracellular matrix deposition. We determined to investigate the morphophysiological mechanisms in mice that were pretreated after induction with bleomycin (BLM). The pretreatment was for 21 days with saline solution, sunflower oil (SO), fish oil (FO), and fish oil nanoemulsion (NEW3). The animals received a daily dose of 50 mg/Kg of docosahexaenoic acid DHA and 10 mg/Kg eicosapentaenoic (EPA) (100 mg/Kg), represented by a daily dose of 40 µL of NEW3. The blank group was treated with the same amount daily (40 µL) during the 21 days of pretreatment. The animals were treated with SO and FO, 100 mg/Kg (containing 58 mg/Kg of polyunsaturated fats/higher% linoleic acid) and 100 mg/Kg (50 mg/Kg of DHA and 10 mg/Kg EPA), respectively. A single dose of 5 mg/mL (50 μL) bleomycin sulfate, by the intratracheal surgical method in BALB/cAnNTac (BALB/c). NEW3 significantly reduced fibrotic progression, which can be evidenced by the protection from loss of body mass, increase in respiratory incursions per minute, decreased spacing of alveolar septa, decreased severity of fibrosis, and changes in the respiratory system. NEW3 attenuated the inflammatory changes developed in the experimental model of pulmonary fibrosis, while group SO showed a significant increase in inflammatory changes. This concluded that the presented results demonstrated that is possible to positively modulate the immune and inflamamtory response to an external agressor, by changing the nutitional intake of specific fatty acids, such as omega-3 placed in fish oil. Moreover, these benefits can be improved by the nanoencapsulation of fish oil in lipid nanoemulsions.
Collapse
Affiliation(s)
- Danielle Galdino de Souza
- Nanobiotechnology Laboratory, Genetics & Morphology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (D.G.d.S.); (D.S.S.); (J.A.V.M.); (T.J.A.P.); (R.B.A.)
| | - Débora Silva Santos
- Nanobiotechnology Laboratory, Genetics & Morphology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (D.G.d.S.); (D.S.S.); (J.A.V.M.); (T.J.A.P.); (R.B.A.)
| | - Karina Smidt Simon
- Applied Immunology Laboratory, Cell Biology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (K.S.S.); (L.C.C.); (A.L.B.)
| | - José Athayde Vasconcelos Morais
- Nanobiotechnology Laboratory, Genetics & Morphology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (D.G.d.S.); (D.S.S.); (J.A.V.M.); (T.J.A.P.); (R.B.A.)
| | - Luísa Coutinho Coelho
- Applied Immunology Laboratory, Cell Biology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (K.S.S.); (L.C.C.); (A.L.B.)
| | - Thyago José Arruda Pacheco
- Nanobiotechnology Laboratory, Genetics & Morphology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (D.G.d.S.); (D.S.S.); (J.A.V.M.); (T.J.A.P.); (R.B.A.)
| | - Ricardo Bentes Azevedo
- Nanobiotechnology Laboratory, Genetics & Morphology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (D.G.d.S.); (D.S.S.); (J.A.V.M.); (T.J.A.P.); (R.B.A.)
| | - Anamélia Lorenzetti Bocca
- Applied Immunology Laboratory, Cell Biology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (K.S.S.); (L.C.C.); (A.L.B.)
| | - César Augusto Melo-Silva
- Respiratory Physiology Laboratory, Faculty of Medicine, University of Brasília, Brasília 70910-900, Brazil;
| | - João Paulo Figueiró Longo
- Nanobiotechnology Laboratory, Genetics & Morphology Department, Institute of Biological Science, University of Brasília, Brasília 70910-900, Brazil; (D.G.d.S.); (D.S.S.); (J.A.V.M.); (T.J.A.P.); (R.B.A.)
- Correspondence:
| |
Collapse
|
5
|
Figueiró Longo JP, Muehlmann LA. How has nanomedical innovation contributed to the COVID-19 vaccine development? Nanomedicine (Lond) 2021; 16:1179-1181. [PMID: 33973802 PMCID: PMC8111932 DOI: 10.2217/nnm-2021-0035] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
6
|
de Lima LI, Faria RS, Franco MS, Roque MC, Arruda Pacheco TJ, Rodrigues MC, Muehlmann LA, Moya SE, Azevedo RB, de Oliveira MC, Figueiró Longo JP. Combined paclitaxel-doxorubicin liposomal results in positive prognosis with infiltrating lymphocytes in lung metastasis. Nanomedicine (Lond) 2020; 15:2753-2770. [PMID: 33179587 DOI: 10.2217/nnm-2020-0201] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Aim: To investigate the effect of liposomes containing the classical cytotoxic drugs paclitaxel and doxorubicin (Lipo-Pacli/Dox), against a metastatic breast cancer model. We also investigated if Lipo-Pacli/Dox was capable of reverting the tolerogenic environment of metastatic lesions. Materials & methods: Immunogenic cell death induction by the Pacli/Dox combination was assessed in vitro. Antitumor activity and in vivo safety of Lipo-Pacli/Dox were evaluated using a 4T1 breast cancer mouse model Results: Lipo-Pacli/Dox, with a size of 189 nm and zeta potential of -5.01 mV, promoted immune system activation and partially controlled the progression of pulmonary metastasis. Conclusion: Lipo-Pacli/Dox was useful to control both primary tumor and lung metastasis in breast cancer (4T1) mice model. Additionally, Lipo-Pacli/Dox acts as an immunological modulator for this metastatic breast cancer model.
Collapse
Affiliation(s)
- Luiza Ianny de Lima
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília/DF 70910 900, Brazil
| | - Raquel Santos Faria
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília/DF 70910 900, Brazil
| | - Marina Santiago Franco
- Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627, Belo Horizonte, Minas Gerais 31270 901, Brazil
| | - Marjorie Coimbra Roque
- Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627, Belo Horizonte, Minas Gerais 31270 901, Brazil
| | - Thyago José Arruda Pacheco
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília/DF 70910 900, Brazil
| | - Mosar Corrêa Rodrigues
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília/DF 70910 900, Brazil
| | - Luis Alexandre Muehlmann
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília/DF 70910 900, Brazil.,Laboratory of Nanoscience & Immunology, Faculty of Ceilandia, University of Brasília, Brasília/DF 72220 900, Brazil
| | - Sergio Enrique Moya
- Soft Matter Nanotechnology Group, CIC biomaGUNE, Paseo Miramón 182, 20014, Donostia-San Sebastián, Spain
| | - Ricardo Bentes Azevedo
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília/DF 70910 900, Brazil
| | - Mônica Cristina de Oliveira
- Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627, Belo Horizonte, Minas Gerais 31270 901, Brazil
| | - João Paulo Figueiró Longo
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília/DF 70910 900, Brazil
| |
Collapse
|
7
|
Longo JPF, Mussi S, Azevedo RB, Muehlmann LA. Issues affecting nanomedicines on the way from the bench to the market. J Mater Chem B 2020; 8:10681-10685. [DOI: 10.1039/d0tb02180f] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The development of innovative nanomedicine has raised the standards over the last few decades.
Collapse
Affiliation(s)
- João Paulo Figueiró Longo
- Department of Genetics and Morphology
- Institute of Biological Sciences
- University of Brasília
- Brasília
- Brazil
| | - Samuel Mussi
- Faculty of Pharmacy
- Federal University of Minas Gerais
- Belo Horizonte
- Brazil
| | - Ricardo Bentes Azevedo
- Department of Genetics and Morphology
- Institute of Biological Sciences
- University of Brasília
- Brasília
- Brazil
| | - Luís Alexandre Muehlmann
- Laboratory of Nanoscience and Immunology
- Faculty of Ceilandia
- University of Brasilia
- Brasilia
- Brazil
| |
Collapse
|
8
|
Zhou Q, Wang K, Dou J, Cao F, Liu F, Yuan H, Mu M, Xu J, Zhang D, Li X, Tian J, Yu J, Liang P. Theranostic liposomes as nanodelivered chemotherapeutics enhanced the microwave ablation of hepatocellular carcinoma. Nanomedicine (Lond) 2019; 14:2151-2167. [PMID: 31411535 DOI: 10.2217/nnm-2018-0424] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Aim: This study aimed to develop indocyanine green- and doxorubicin-loaded liposomes (DILPs) as theranostic nanoplatform for the detection of hepatocellular carcinoma (HCC) and as an efficient chemotherapeutic to enhance microwave ablation. Materials & methods: DILPs were synthesized and thoroughly characterized. Biocompatibility, tumor uptake and accumulation, and synergistic ablation-chemotherapeutic efficiency were systematically explored in them. In addition, human HCC surgical samples were used to test the affinity of DILPs for HCC. Results: The combination of microwave ablation and DILPs enhanced the ablation efficiency of HCC with apparent tumor inhibition. DILPs exhibited excellent diagnostic ability and could detect 2.5-mm HCC lesions via optoacoustic tomography imaging. DILPs had better affinity for human HCC surgical samples compared with normal liver tissue. Conclusion: Theranostic DILPs could serve as promising nanoparticles for treatment and management of HCC in the clinic.
Collapse
Affiliation(s)
- Qunfang Zhou
- Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, PR China.,Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, PR China
| | - Kun Wang
- Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, PR China
| | - Jianping Dou
- Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Feng Cao
- Department of Cardiology, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Fengyong Liu
- Department of Interventional Radiology, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Hongjun Yuan
- Department of Interventional Radiology, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Mengjuan Mu
- Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Jinshun Xu
- Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Dongyun Zhang
- Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Xin Li
- Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Jie Tian
- Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, PR China
| | - Jie Yu
- Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, PR China
| | - Ping Liang
- Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, PR China
| |
Collapse
|